| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/08/2009 | CN101402632A Aryl hydrazide compounds with antineoplastic activity |
| 04/08/2009 | CN101402626A Reutilization method for low pressure by-product steam in benzoic anhydride producing process |
| 04/08/2009 | CN101402625A Process for producing aromatic diaether dianhydride monomer |
| 04/08/2009 | CN101402624A Method for producing trimellitic anhydride with pseudocumene liquid phase air segmenting hydrocarbonylation |
| 04/08/2009 | CN101402623A 3-substituted benzene phthalein compounds with biological activity |
| 04/08/2009 | CN101402622A Synthesis and uses of 4,6,4'-trihydroxy-3',5'-dimethoxy aurone and its derivative |
| 04/08/2009 | CN101402621A Aryl furfuran formyl hydrazone compounds with antineoplastic activity |
| 04/08/2009 | CN101402620A Benzoyl hydrazone compounds with antineoplastic activity |
| 04/08/2009 | CN101402619A Novel 2-deoxidizedfructofuranose derivative, preparation method and medical uses thereof |
| 04/08/2009 | CN101402618A Apparatus and method for abstraction distillation separation of tetrahydrofuran-ethyl alcohol azeotropy article |
| 04/08/2009 | CN101402606A Nitrogen heterocyclic ring substituted arylpropenone compounds, preparation method and application thereof |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN100475969C Cytochrome C oxidase enzyme complex |
| 04/08/2009 | CN100475819C Pseudopolymorphic forms of a HIV protease inhibitor |
| 04/08/2009 | CN100475801C Process for the preparation of n-alkyl-2(hydroxy-4 benzoyl)-3 benzofurans and intermediates thereof |
| 04/08/2009 | CN100475787C Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 04/07/2009 | US7514573 Processes for the manufacture of chiral and racemic forms of 3-aminotetrahydrofurans, their salts and derivatives |
| 04/07/2009 | US7514452 3-(4-hexylphenyl)-2-furancarboxylic acid 2-(4-hydroxy-3-nitrobenzoyl)hydrazide; nonpeptidergic glucagon receptor antagonist; orally; decrease blood sugar levels; hypoglycemic agent; dabetes mellitus type I and II, obesity, hyperlipidemia, gastrointestinal disorders |
| 04/07/2009 | US7514439 Oxime derivative and preparations thereof |
| 04/07/2009 | US7514127 Dibenzofuran derivatives, dibenzothiophene derivatives and fluorene derivatives |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2276278C Amine compounds, their production and use |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/07/2009 | CA2174494C Benzofurans |
| 04/02/2009 | WO2009040828A1 A process for purification of mycophenolic acid |
| 04/02/2009 | WO2009040246A1 Improved vaporisation in oxidation to phthalic anhydride |
| 04/02/2009 | WO2009040245A1 Improved mixing in oxidation to phthalic anhydride |
| 04/02/2009 | WO2008059514A3 Process for preparing escitalopram |
| 04/02/2009 | US20090088545 Polymerziable liquid crystal compound, polymerziable liquid crystal composition comprising the same, and polymer produced using them |
| 04/02/2009 | US20090088469 Method for the preparation of citalopram |
| 04/02/2009 | US20090088468 Novel epoprostenol formulation and method of making thereof |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/01/2009 | EP2042496A1 Method for manufacturing 4-aminobut-2-enolids |
| 04/01/2009 | EP2042495A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/01/2009 | EP2042480A1 Aminoindan derivative or salt thereof |
| 04/01/2009 | EP2041107A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 04/01/2009 | EP2041089A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 04/01/2009 | EP2040690A1 Inhibitors of cxcr2 |
| 04/01/2009 | EP2040688A1 New cxcr2 inhibitors |
| 04/01/2009 | EP1794140B1 Process for the preparation of escitalopram |
| 04/01/2009 | EP1755585A4 Transthyretin stabilization |
| 04/01/2009 | EP1664012B1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
| 04/01/2009 | EP1620429B1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 04/01/2009 | EP1487575B2 Method for the production of a catalyst containing vanadium, phosphorus, and oxygen |
| 04/01/2009 | CN101400666A Method for the synthesis of 5-alkoxymethylfurfural ethers and their use |
| 04/01/2009 | CN101397919A Method for recycling steam in chemical production |
| 04/01/2009 | CN101397286A Method for continuous crystallisation of vitamin C |
| 04/01/2009 | CN101397285A Method for preparing alkyl furanone by low-temperature condensation method |
| 03/31/2009 | US7511168 Alkylation of a hydroxy-protected 2-(amido, carboxy, or thiocarboxy)methyl-4-hydroxypent-2-enone at the 3-position, deprotecting, resolving diastereomers by crystallization; simplification; cost efficiency |
| 03/31/2009 | US7511161 Dissolving crude mixture in a water immiscible solvent, washing with a dilute aqueous solution of a partial alkali salt of a polybasic acid, salt formation; simplified industrial scale synthesis and purification |
| 03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/31/2009 | CA2356121C Novel propargylether derivatives |
| 03/31/2009 | CA2329353C Method for producing mixtures of 1,4-butanediol, tetrahydrofuran and .gamma.-butyrolactone |
| 03/26/2009 | WO2009036899A1 Method for producing 4-aminobut-2-enolides |
| 03/26/2009 | WO2009036898A1 Method for producing 4-aminobut-2-enolides |
| 03/26/2009 | WO2009014267A3 Imidate compound and use thereof for pest control |
| 03/26/2009 | WO2005067580A3 Naphthofluorescein-based metal sensors, and methods of making and using the same |
| 03/26/2009 | US20090082582 Process For Preparing [2-(2,3- Dihydrobenzofuran - Or Benzofuran-7-Yloxy)Ethyl]-(3 -Cyclopent-1-Ylbenzyl)Amine Derivatives and Synthesis Intermediate |
| 03/26/2009 | US20090082434 Dihydrobenzofuranyl Alkanamine Derivatives and Methods for Using Same |
| 03/26/2009 | US20090082433 Preventative treatment and remission of allergic diseases |
| 03/26/2009 | US20090082432 Deuterium-enriched ramelteon |
| 03/26/2009 | US20090082392 Substituted Carboxylic Acids |
| 03/25/2009 | EP2039678A1 Method for manufacturing 4-aminobut-2-enolids |
| 03/25/2009 | EP2039677A1 Organic compounds containing heteroatoms and their use in ziegler-natta catalyst with single activation center |
| 03/25/2009 | EP2038253A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/25/2009 | EP1681280B1 Novel phenol derivatives and antitrypanosoma preventive/therapeutic agent containing the same as active ingredient |
| 03/25/2009 | EP1641740B1 Method for producing an optically active nitro compound |
| 03/25/2009 | EP1296935B1 Process for the preparation of substituted octanoyl amides |
| 03/25/2009 | CN101395146A Process for preparing [2-(2,3-dihydrobenzofuran- or benzofuran-7-yloxy)ethyl]-(3-cyclopent-1-ylbenzyl)amine derivatives and synthesis intermediate |
| 03/25/2009 | CN101395106A Dibenzoanthracene compound and organic light emitting device having the same |
| 03/25/2009 | CN100471847C Eremophilane containing chlorine atom in Heizituowu and its anti-biotic and cell-toxin activity |
| 03/25/2009 | CN100471846C Cyanoacrylate compounds and their application in pesticide |
| 03/25/2009 | CN100471844C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 03/24/2009 | US7507866 Decarboxylation/hydroxylation without the release of carbon monoxide by using a mixed-oxide, supported, hydrogenation catalyst based on rhenium oxide with an absense of ruthenium and, in some cases, platinum and palladium; autoclaving malic acid to obtain hydroxybutyrolactone and 1,2,4-butanetriol |
| 03/24/2009 | US7507860 Androgen modulators |
| 03/24/2009 | US7507841 Cannabinoid receptor modulator |
| 03/24/2009 | US7507840 Nonlinear optically active compounds that include a pi-donor conjugated to a pi-acceptor through a pi-electron conjugated bridge |
| 03/24/2009 | US7507839 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants |
| 03/24/2009 | US7507830 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles |
| 03/24/2009 | US7507817 Glaucome therapy; vision defects |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507754 e.g. N-{4-[4-(5-Methoxy-pyridin-2-yl)-phenoxymethyl]-5-methyl-furan-2-carbonyl}-2-methyl-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 03/24/2009 | CA2329477C Method for producing 1,4-butanediol |
| 03/19/2009 | WO2009035951A2 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2009035949A2 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2009033488A1 Method for manufacture of escitalopram |
| 03/19/2009 | WO2009033326A1 Ascorbic acid derivates, their preparation methods, intermediates and uses in cosmetics |
| 03/19/2009 | WO2009016375A3 Polyglycerol ethers of sorbitan carboxylic acid esters |
| 03/19/2009 | WO2009014343A3 Ascorbic acid derivatives having alpha-lipoyl groups and process for preparing the same |
| 03/19/2009 | US20090076268 Facile assembly of fused benzofuro-heterocycles |
| 03/19/2009 | US20090076201 (meth) acryloyloxytetrahydrofurans and process for production thereof |
| 03/19/2009 | US20090076137 Deuterium-enriched dronedarone |
| 03/19/2009 | US20090076135 Deuterium-enriched hydromorphone |
| 03/19/2009 | US20090076062 Organic Compounds |
| 03/19/2009 | US20090076012 Modulation of pathogenicity |
| 03/19/2009 | US20090075989 Non-steroidal progesterone receptor modulators |
| 03/19/2009 | US20090075938 Treatment of duchenne muscular dystrophy |
| 03/19/2009 | US20090075908 Agent For Strengthening Calcium Containing Tissue and Use Thereof |